Vancouver, Canada, June 28, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, announces advancement in its proprietary MEAI- based binge behavior regulator program through the granting of patent approval […]
Category Archives: Pr Newswire
Announcing Expansion in Brazil with More Portuguese Offerings BEIJING, June 28, 2024 /PRNewswire/ — On June 27, iQIYI, an innovative market-leading online entertainment service in China, concluded its fourth Annual Content Showcase virtually in North America, unveiling an impressive lineup of over 250 new Asian shows. The company also announced the expansion of its operations […]
NANJING, China, SHANGHAI and SAN JOSE, Calif., June 28, 2024 /PRNewswire/ — IASO Biotechnology (“IASO Bio”), a biopharmaceutical company engaged in discovering, developing, manufacturing, and marketing innovative cell therapies and antibody products, today announces that the investigational new drug (IND) application for RD118, an independently developed, fully human GPRC5D-targeting chimeric antigen receptor T-cell (CAR-T) therapy, […]
BEIJING, June 28, 2024 /PRNewswire/ — A report from People’s Daily: This year marks the 70th anniversary of the Five Principles of Peaceful Coexistence. Over the past seven decades, these principles have been widely accepted and recognized by countries across the world, becoming an important norm governing contemporary international relations. In the wake of the […]
DALIAN, China, June 28, 2024 /PRNewswire/ — From June 25 to 27, 2024, the World Economic Forum Annual Meeting of the New Champions, also known as the “Summer Davos Forum,” was held in Dalian, China, attracting global leaders from various sectors. Among the influential speakers were Dean Li Haitao and Professor of Marketing Zhu Rui from […]
VICTORIA, Seychelles, June 28, 2024 /PRNewswire/ — Leading Web3 wallet and DeFi platform Bitget Wallet has announced a joint investment with crypto investment firm Foresight X in Tomarket, a decentralized trading platform for emerging asset classes. Bitget Wallet Announces Investment in New Asset Trading Platform Tomarket, Targeting Trillion-Dollar Markets Beyond DEXs Developed by industry experts […]
28
Jun
Jun
China is the Third Country to Launch LEQEMBI Following the United States and Japan TOKYO and CAMBRIDGE, Mass., June 27, 2024 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that the humanized anti-soluble aggregated amyloid-beta […]
Pr Newswire
Ensho Therapeutics Launches with Phase 2-Ready Oral α4β7 Inhibitor for Inflammatory Bowel Disease
28
Jun
Jun
Portfolio of Oral Selective α4β7 Inhibitors Acquired from EA Pharma, Eisai’s GI Subsidiary Phase 2 Clinical Program in Ulcerative Colitis to Start in First Half of 2025 with Lead Asset Seasoned Executive Team with History of Execution in Inflammatory Bowel Disease Drug Development toJoin Ensho on July 1 Founded by Neena Bitritto-Garg, Veteran Biotech Equity […]
28
Jun
Jun
Meg Marshall Joins the Administrative Team at the Longtime Practice Serving the Philadelphia Area DOYLESTOWN, Pa., June 27, 2024 (GLOBE NEWSWIRE) — Drs. Brian and Annie Buinewicz, owners of Buinewicz Plastic Surgery in the Philadelphia area, recently welcomed a new addition to their team known for providing plastic surgery procedures, nonsurgical cosmetic treatments, and more […]
Pr Newswire
Worldwide License Agreement for EA1080, Oral Selective α4β7 Integrin Antagonist, Signed between EA Pharma and Ensho Therapeutics
28
Jun
Jun
Ensho Acquired Rights to Develop and Commercialize EA1080 and Portfolio of Other Oral Selective α4β7 Integrin Antagonists in All Territories Excluding Japan, China, Hong Kong, Macau, South Korea, Taiwan and ASEAN CHUO-KU, TOKYO and MORRIS PLAINS, N.J., June 27, 2024 (GLOBE NEWSWIRE) — EA Pharma Co., Ltd. (President, Hidenori Yabune; “EA Pharma”) and Ensho Therapeutics, […]